Ma P; Ou H; Sun Z, et al., IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis. J Agric Food Chem 2024, 72 (13), 7167-7178.
Wang C; Zeng W; Wang L, et al., Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species. Drug Dev Res 2024, 85 (4), e22213.
